These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36982588)

  • 1. Tamoxifen Modulates the Immune Landscape of the Tumour Microenvironment: The Paired Siglec-5/14 Checkpoint in Anti-Tumour Immunity in an In Vitro Model of Breast Cancer.
    Wielgat P; Rogowski K; Czarnomysy R; Wawrusiewicz-Kurylonek N; Narejko K; Bielawski K; Car H
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Paired Siglecs in Brain Tumours Therapy: The Immunomodulatory Effect of Dexamethasone and Temozolomide in Human Glioma In Vitro Model.
    Wielgat P; Wawrusiewicz-Kurylonek N; Czarnomysy R; Rogowski K; Bielawski K; Car H
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialylation pattern in lung epithelial cell line and Siglecs expression in monocytic THP-1 cells as cellular indicators of cigarette smoke - induced pathology in vitro.
    Wielgat P; Trofimiuk E; Czarnomysy R; Holownia A; Braszko JJ
    Exp Lung Res; 2018 Apr; 44(3):167-177. PubMed ID: 29781747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
    Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A
    Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity.
    Ibarlucea-Benitez I; Weitzenfeld P; Smith P; Ravetch JV
    Proc Natl Acad Sci U S A; 2021 Jun; 118(26):. PubMed ID: 34155121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients.
    Benmerzoug S; Chevalier MF; Verardo M; Nguyen S; Cesson V; Schneider AK; Dartiguenave F; Rodrigues-Dias SC; Lucca I; Jichlinski P; Roth B; Nardelli-Haefliger D; Derré L
    Eur Urol Focus; 2022 May; 8(3):748-751. PubMed ID: 34147404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9.
    Rodriguez E; Boelaars K; Brown K; Eveline Li RJ; Kruijssen L; Bruijns SCM; van Ee T; Schetters STT; Crommentuijn MHW; van der Horst JC; van Grieken NCT; van Vliet SJ; Kazemier G; Giovannetti E; Garcia-Vallejo JJ; van Kooyk Y
    Nat Commun; 2021 Feb; 12(1):1270. PubMed ID: 33627655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sialoglycan-Siglec-E checkpoint axis in dexamethasone-induced immune subversion in glioma-microglia transwell co-culture system.
    Wielgat P; Czarnomysy R; Trofimiuk E; Car H
    Immunol Res; 2019 Oct; 67(4-5):348-357. PubMed ID: 31741237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth.
    Tanida S; Akita K; Ishida A; Mori Y; Toda M; Inoue M; Ohta M; Yashiro M; Sawada T; Hirakawa K; Nakada H
    J Biol Chem; 2013 Nov; 288(44):31842-52. PubMed ID: 24045940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA:Siglec crosstalk in cancer progression.
    Mustafov D; Ahmad MS; Serrano A; Braoudaki M; Siddiqui SS
    Curr Opin Chem Biol; 2024 Aug; 81():102502. PubMed ID: 39029379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sialic acid-Siglec immune checkpoint: an opportunity to enhance immune responses and therapy effectiveness in melanoma.
    Coccimiglio M; Chiodo F; van Kooyk Y
    Br J Dermatol; 2024 Apr; 190(5):627-635. PubMed ID: 38197441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates.
    Angata T; Hayakawa T; Yamanaka M; Varki A; Nakamura M
    FASEB J; 2006 Oct; 20(12):1964-73. PubMed ID: 17012248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of a sialic acid-recognizing lectin Siglec-9 modulates adhesion dynamics of cancer cells via calpain-mediated protein degradation.
    Sabit I; Hashimoto N; Matsumoto Y; Yamaji T; Furukawa K; Furukawa K
    J Biol Chem; 2013 Dec; 288(49):35417-27. PubMed ID: 24145038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of lipophilic ligands of Siglec5 and -14 that modulate innate immune responses.
    Suematsu R; Miyamoto T; Saijo S; Yamasaki S; Tada Y; Yoshida H; Miyake Y
    J Biol Chem; 2019 Nov; 294(45):16776-16788. PubMed ID: 31551352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viewing Siglecs through the lens of tumor immunology.
    Fraschilla I; Pillai S
    Immunol Rev; 2017 Mar; 276(1):178-191. PubMed ID: 28258691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
    Angata T; Varki A
    J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
    Roy S; Mandal C
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
    Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
    Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tools to study and target the Siglec-sialic acid axis in cancer.
    Läubli H; Kawanishi K; George Vazhappilly C; Matar R; Merheb M; Sarwar Siddiqui S
    FEBS J; 2021 Nov; 288(21):6206-6225. PubMed ID: 33251699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway.
    Grabenstein S; Barnard KN; Anim M; Armoo A; Weichert WS; Bertozzi CR; Parrish CR; Willand-Charnley R
    Glycobiology; 2021 Nov; 31(10):1279-1294. PubMed ID: 34192335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.